Pan W, Tsokos M, Li W, Tsokos G
Immunometabolism (Cobham). 2025; 7(1):e00056.
PMID: 39944077
PMC: 11812671.
DOI: 10.1097/IN9.0000000000000056.
Goncu B, Gurol A
Hum Cell. 2025; 38(2):42.
PMID: 39775468
DOI: 10.1007/s13577-024-01170-y.
Acero-Bedoya S, Higgs E, Martinez A, Tonea R, Gajewski T
J Immunother Cancer. 2024; 12(10).
PMID: 39461876
PMC: 11529514.
DOI: 10.1136/jitc-2024-009588.
Lee J, Yurkovetskiy L, Reiman D, Frommer L, Strong Z, Chang A
Nat Commun. 2024; 15(1):7688.
PMID: 39227386
PMC: 11372096.
DOI: 10.1038/s41467-024-51869-7.
Brownlie R, Salmond R
Mol Cell Biol. 2024; 44(10):443-452.
PMID: 39039893
PMC: 11486154.
DOI: 10.1080/10985549.2024.2378810.
A novel gain-of-function phosphorylation site modulates PTPN22 inhibition of TCR signaling.
Zhuang C, Yang S, Gonzalez C, Ainsworth R, Li S, Kobayashi M
J Biol Chem. 2024; 300(6):107393.
PMID: 38777143
PMC: 11237943.
DOI: 10.1016/j.jbc.2024.107393.
Disruption of post-thymic tolerance in skin-reactive TCR transgenic mice through the interaction of lymphopenia and intestinal microbiota.
Hayabuchi H, Tokifuji Y, Takahashi H, Amagai M, Yoshimura A, Chikuma S
Int Immunol. 2024; 36(8):413-424.
PMID: 38576231
PMC: 11245856.
DOI: 10.1093/intimm/dxae018.
Autoimmunity-associated allele of tyrosine phosphatase gene PTPN22 enhances anti-viral immunity.
Orozco R, Marquardt K, Pratumchai I, Shaikh A, Mowen K, Domissy A
PLoS Pathog. 2024; 20(3):e1012095.
PMID: 38512979
PMC: 10987006.
DOI: 10.1371/journal.ppat.1012095.
Targeting Protein Tyrosine Phosphatases to Improve Cancer Immunotherapies.
Salmond R
Cells. 2024; 13(3.
PMID: 38334623
PMC: 10854786.
DOI: 10.3390/cells13030231.
OT-I TCR Transgenic Mice to Study the Role of PTPN22 in Anti-cancer Immunity.
Brownlie R, Zamoyska R, Salmond R
Methods Mol Biol. 2023; 2743:81-92.
PMID: 38147209
DOI: 10.1007/978-1-0716-3569-8_5.
Protein tyrosine phosphatases as emerging targets for cancer immunotherapy.
Qu Z, Dong J, Zhang Z
Br J Pharmacol. 2023; .
PMID: 38116815
PMC: 11186978.
DOI: 10.1111/bph.16304.
T-helper cells flexibility: the possibility of reprogramming T cells fate.
Khantakova J, Sennikov S
Front Immunol. 2023; 14:1284178.
PMID: 38022605
PMC: 10646684.
DOI: 10.3389/fimmu.2023.1284178.
The Tyrosine Phosphatase Activity of PTPN22 Is Involved in T Cell Development via the Regulation of TCR Expression.
Bai B, Li T, Zhao J, Zhao Y, Zhang X, Wang T
Int J Mol Sci. 2023; 24(19).
PMID: 37833951
PMC: 10572452.
DOI: 10.3390/ijms241914505.
R620W gene editing in T cells enhances low-avidity TCR responses.
Anderson W, Barahmand-Pour-Whitman F, Linsley P, Cerosaletti K, Buckner J, Rawlings D
Elife. 2023; 12.
PMID: 36961507
PMC: 10065793.
DOI: 10.7554/eLife.81577.
Genetic Background and Molecular Mechanisms of Juvenile Idiopathic Arthritis.
La Bella S, Rinaldi M, Di Ludovico A, Di Donato G, Di Donato G, Salpietro V
Int J Mol Sci. 2023; 24(3).
PMID: 36768167
PMC: 9916312.
DOI: 10.3390/ijms24031846.
Hereditable variants of classical protein tyrosine phosphatase genes: Will they prove innocent or guilty?.
Hendriks W, van Cruchten R, Pulido R
Front Cell Dev Biol. 2023; 10:1051311.
PMID: 36755664
PMC: 9900141.
DOI: 10.3389/fcell.2022.1051311.
Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders.
Stanford S, Bottini N
Nat Rev Drug Discov. 2023; 22(4):273-294.
PMID: 36693907
PMC: 9872771.
DOI: 10.1038/s41573-022-00618-w.
The Non-Receptor Protein Tyrosine Phosphatase PTPN6 Mediates a Positive Regulatory Approach From the Interferon Regulatory Factor to the JAK/STAT Pathway in .
Luo M, Xu X, Liu X, Shen W, Yang L, Zhu Z
Front Immunol. 2022; 13:913955.
PMID: 35844582
PMC: 9276969.
DOI: 10.3389/fimmu.2022.913955.
EGR2 Deletion Suppresses Anti-DsDNA Autoantibody and IL-17 Production in Autoimmune-Prone B6/lpr Mice: A Differential Immune Regulatory Role of EGR2 in B6/lpr Versus Normal B6 Mice.
Dai R, Wang Z, Heid B, Eden K, Reilly C, Ahmed S
Front Immunol. 2022; 13:917866.
PMID: 35784356
PMC: 9241489.
DOI: 10.3389/fimmu.2022.917866.
Association of PTPN22 SNP1858 (rs2476601) and Gene SNP1123 (rs2488457) Polymorphism With Primary Immune Thrombocytopenia Susceptibility: A Meta-Analysis of Case-Control Studies and Trial Sequential Analysis.
Tian H, Xu W, Wen L, Tang L, Zhang X, Song T
Front Genet. 2022; 13:893669.
PMID: 35692826
PMC: 9174638.
DOI: 10.3389/fgene.2022.893669.